Canadian Journal of Infectious Diseases and Medical Microbiology (Jan 2008)
Economic Evaluation of Voriconazole for the Treatment of Candidemia in Canadian Adults
Abstract
BACKGROUND: Candidemia is a common cause of nosocomial bloodstream infection. When selecting therapeutic treatments for candidemia, cost-effectiveness is an important consideration. The present study assessed the cost-effectiveness of voriconazole for the treatment of candidemia.